Kissei Pharmaceutical Co Ltd 2023 Annual Report with Sustainability Disclosures
Company: Kissei Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 31
The report highlights the Kissei Group's fiscal 2022 consolidated net sales of ¥67,493 million and the launch of TAVALISSE® in April 2023 for chronic idiopathic thrombocytopenic purpura. It also describes the reorganization of the SDGs Promotion Committee into the Sustainability Promotion Committee and the Company's June 2023 endorsement of TCFD recommendations. Climate-related reporting includes a fiscal 2030 target to reduce Scope 1 and 2 CO2 emissions by 46% compared with fiscal 2013.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.